Dr. Florescu said a separate study looked at the same drug and its effectiveness for outpatient care following a confirmed COVID infection. That study has good initial results and the pharmaceutical company MERCK is sending a request to the Food and Drug Administration (FDA) for emergency approval. Dr. Florescu and UNMC’s study examines the pill’s use for preventative care.